An elamipretide supplement isn't a real OTC product: elamipretide is a prescription mitochondrial peptide studied for Barth syndrome and heart failure.
Elamipretide is not a dietary supplement. It is a synthetic, mitochondria-targeted peptide that is regulated as a prescription drug in the United States, where the FDA approved it under the brand name Forzinity for Barth syndrome. Most products marketed online as an "elamipretide supplement" are unapproved research chemicals, not a legal over-the-counter product.
What Elamipretide Actually Is
Elamipretide is a four-amino-acid peptide originally developed as SS-31 and later studied under the names MTP-131 and Bendavia. It belongs to a small class of compounds designed to concentrate inside mitochondria rather than throughout the whole body.
The elamipretide structure pairs aromatic residues with positively charged ones, which lets the molecule associate with cardiolipin on the inner mitochondrial membrane. Researchers believe that binding helps stabilize cristae structure, reduce oxidative stress, and support ATP production.
That mechanism is well studied in cells, but improved mitochondrial function in a lab dish does not automatically translate into clinical benefit. Human trials have produced a mix of encouraging and disappointing results depending on the condition.
Why There Is No Real Elamipretide Supplement
Because elamipretide is an approved prescription drug, it cannot legally be sold as a dietary supplement in the United States. Any capsule, powder, or dropper labeled "elamipretide" is therefore an unapproved drug product.
- Purity and identity are usually unverified, and independent testing of gray-market peptides often finds missing or incorrect third-party certificates.
- Studied doses used daily subcutaneous injections, not oral capsules, so label directions rarely match the research protocol.
- Sterility is a genuine concern, since most research-grade peptide is handled as a powder intended for injection.
- There is no regulatory recourse if a product causes harm or contains something other than elamipretide.
When a website offers elamipretide as an oral supplement, treat the listing as an unregulated research chemical. You cannot confirm what is in the vial, and no agency has reviewed it for safety or dosing.
Elamipretide Uses in Research and Clinical Trials
Elamipretide uses in research center on diseases where mitochondria fail, and the results differ sharply by condition. The best-known programs include:
- Barth syndrome — a rare X-linked disorder that disrupts cardiolipin metabolism and causes cardiomyopathy, muscle weakness, and low neutrophil counts.
- Primary mitochondrial myopathy — the MMPOWER trials measured walking performance, and results did not clearly separate drug from placebo.
- Heart failure — an early phase 2 study did not meet its primary endpoint, so the drug is not a heart failure treatment.
- Dry age-related macular degeneration and Leber hereditary optic neuropathy — smaller exploratory studies with limited outcome data.
The elamipretide barth syndrome program produced the evidence behind the drug's approval, based on functional improvements in patients weighing at least 30 kg. In elamipretide heart failure research, the picture is different: the drug failed to beat placebo on the trial's main goal, and regulators did not clear it for that use.
How Elamipretide Compares With Popular Mitochondrial Supplements
Many people arrive at elamipretide from the supplement aisle, so it helps to compare legal status, price, and evidence side by side.
| Product | Category | US legal status | Typical advertised cost | Human evidence |
|---|---|---|---|---|
| Elamipretide (Forzinity) | Prescription mitochondria-targeted peptide | FDA-approved for Barth syndrome; prescription only | Specialty pharmacy pricing; insurance dependent | Approval supported by Barth syndrome data; mixed results in heart failure and myopathy |
| CoQ10 (ubiquinol) | Dietary supplement | Legal OTC | $15–$40 per month | Mixed; modest signal in some heart failure studies |
| MitoQ (mitoquinone) | Dietary supplement | Legal OTC | $50–$70 per month | Small trials; limited clinical outcome data |
| Nicotinamide riboside / NMN | Dietary supplement | Legal OTC, though NMN status has shifted | $30–$70 per month | Raises NAD+ levels; clinical benefits remain unproven |
The elamipretide cost is in a completely different category from supplement pricing. Prescription pricing for a rare-disease peptide runs through specialty pharmacies and insurance, and list prices are frequently in the tens of thousands of dollars per year or more.
A sixty-dollar bottle advertised as elamipretide is not the same molecule as the approved drug, no matter how the label is worded. Consumers comparing price alone are comparing a regulated injectable to an untested powder.
Safety and Legal Considerations
In clinical trials, elamipretide was generally tolerated, with injection-site reactions the most frequently reported complaint. That safety record applies to the studied injectable drug under medical supervision, not to unknown powders sold under the same name.
Self-dosing with unapproved peptides carries real risks, including sterility failures, dosing errors, allergic reactions, and interactions with prescription medications. Anyone with a diagnosed mitochondrial condition should talk with a healthcare professional before buying peptides online.
The same caution applies to other gray-market products, including the cjc-1295 oral supplement listings that appear on the same websites. Buying from an unregulated vendor does not make an unapproved drug safe, tested, or legal.
Key Takeaways
- Elamipretide is a prescription mitochondrial peptide, not a dietary supplement.
- The FDA approved elamipretide as Forzinity for Barth syndrome, and it is not approved for anti-aging, weight loss, or general cardiac care.
- No legal over-the-counter elamipretide supplement exists in the United States.
- Evidence in heart failure and mitochondrial myopathy is mixed, and a phase 2 heart failure trial missed its primary endpoint.
- Consult a healthcare professional before using any unapproved peptide product.
Frequently Asked Questions
Can I buy elamipretide as a supplement?
No. Elamipretide is regulated as a prescription drug, so it cannot legally be sold as a dietary supplement in the United States. Products labeled that way are unapproved research chemicals with no verified purity, dose, or sterility.
Is elamipretide FDA approved?
Yes, the FDA approved elamipretide under the brand name Forzinity for Barth syndrome in patients weighing at least 30 kg. It is not approved for heart failure, general mitochondrial support, anti-aging, or athletic performance.
What is elamipretide used for?
Elamipretide is used in the approved setting to treat Barth syndrome, a rare genetic disorder affecting cardiolipin metabolism and heart function. It has also been studied in primary mitochondrial myopathy, heart failure, and dry macular degeneration, with mixed results.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.